OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.[ Read More ]
The intrinsic value of one OCX stock under the base case scenario is HIDDEN Compared to the current market price of 2.61 USD, OncoCyte Corporation is HIDDEN
Current Assets | 10.7 M |
Cash & Short-Term Investments | 9.43 M |
Receivables | 484 K |
Other Current Assets | 782 K |
Non-Current Assets | 64.2 M |
Long-Term Investments | 0 |
PP&E | 5.44 M |
Other Non-Current Assets | 58.8 M |
Current Liabilities | 7.19 M |
Accounts Payable | 953 K |
Short-Term Debt | 1.33 M |
Other Current Liabilities | 4.91 M |
Non-Current Liabilities | 42.1 M |
Long-Term Debt | 2.2 M |
Other Non-Current Liabilities | 39.9 M |
Revenue | 1.5 M |
Cost Of Revenue | 1.09 M |
Gross Profit | 413 K |
Operating Expenses | 25.6 M |
Operating Income | -25.1 M |
Other Expenses | 2.64 M |
Net Income | -27.8 M |
Net Income | -27.8 M |
Depreciation & Amortization | 1.68 M |
Capital Expenditures | -281 K |
Stock-Based Compensation | 6.57 M |
Change in Working Capital | -3.97 M |
Others | 851 K |
Free Cash Flow | -23.6 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
1 month ago
Oct 02, 2024
|
Bought 100 K USD
|
James Andrea S.
Chief Financial Officer |
+ 33670
|
2.97 USD |
1 month ago
Oct 02, 2024
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
1 month ago
Oct 02, 2024
|
Bought 3.88 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 1315339
|
2.948 USD |
7 months ago
Apr 11, 2024
|
Bought 7.06 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 2420000
|
2.9164 USD |
7 months ago
Apr 11, 2024
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
7 months ago
Apr 11, 2024
|
Bought 10 K USD
|
Riggs Josh
CEO and President |
+ 3390
|
2.95 USD |
7 months ago
Apr 11, 2024
|
Bought 100 K USD
|
Arno Andrew
Director |
+ 33898
|
2.95 USD |
1 year ago
Jun 14, 2023
|
Bought 6.45 K USD
|
KINGSLEY ALFRED D
Director |
+ 30000
|
0.2149 USD |
1 year ago
Apr 05, 2023
|
Bought 200 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 663000
|
0.3017 USD |
1 year ago
Apr 03, 2023
|
Bought 8.09 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 26827638
|
0.3017 USD |
1 year ago
Apr 03, 2023
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
1 year ago
Dec 23, 2022
|
Bought 87.9 K USD
|
Arno Andrew
Director |
+ 250000
|
0.3515 USD |
1 year ago
Dec 23, 2022
|
Bought 24.7 K USD
|
Gutfreund John Peter
Director |
+ 75000
|
0.3297 USD |
1 year ago
Dec 22, 2022
|
Bought 7.12 K USD
|
KINGSLEY ALFRED D
Director |
+ 25000
|
0.285 USD |
2 years ago
Aug 17, 2022
|
Bought 17.4 K USD
|
Last Andrew J.
director: |
+ 20000
|
0.87 USD |
2 years ago
Aug 17, 2022
|
Bought 6.75 K USD
|
Arno Andrew
director: |
+ 7500
|
0.9 USD |
2 years ago
Aug 16, 2022
|
Bought 38.4 K USD
|
ANDREWS RONALD ASBURY
President & CEO |
+ 40000
|
0.96 USD |
2 years ago
Aug 15, 2022
|
Bought 4.85 K USD
|
KINGSLEY ALFRED D
director: |
+ 5000
|
0.97 USD |
2 years ago
Aug 15, 2022
|
Bought 23.2 K USD
|
Gutfreund John Peter
director: |
+ 25000
|
0.93 USD |
2 years ago
Aug 15, 2022
|
Bought 10 K USD
|
GRIFFITH MELINDA
director: |
+ 10000
|
1 USD |
2 years ago
Aug 15, 2022
|
Bought 9.98 K USD
|
Carter Jennifer L.
director: |
+ 10500
|
0.95 USD |
2 years ago
Aug 15, 2022
|
Bought 112 K USD
|
Arno Andrew
director: |
+ 115523
|
0.97 USD |
2 years ago
Aug 15, 2022
|
Bought 32.1 K USD
|
Arno Andrew
Director |
+ 34477
|
0.93 USD |
2 years ago
Jun 24, 2022
|
Sell 13.2 K USD
|
Kamen Efrem
director: |
- 12517
|
1.0514 USD |
2 years ago
Jun 24, 2022
|
Sell 13.2 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
- 12517
|
1.0514 USD |
2 years ago
Jun 24, 2022
|
Sell 41.6 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
- 40464
|
1.0269 USD |
2 years ago
Jun 24, 2022
|
Sell 11.5 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
- 10964
|
1.0514 USD |
2 years ago
Jun 24, 2022
|
Sell 36.4 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
- 35441
|
1.0269 USD |
2 years ago
Apr 14, 2022
|
Bought 72.6 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 57630
|
1.26 USD |
2 years ago
Apr 14, 2022
|
Bought 23.6 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 19210
|
1.227 USD |
2 years ago
Apr 14, 2022
|
Bought 116 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 92370
|
1.26 USD |
2 years ago
Apr 14, 2022
|
Bought 37.8 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 30790
|
1.227 USD |
2 years ago
May 18, 2022
|
Sell 9.27 K USD
|
Yu Li
VP Cntrllr/Prncpl Acctng Offcr |
- 8128
|
1.14 USD |
2 years ago
Apr 14, 2022
|
Bought 72.6 K USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 57630
|
1.26 USD |
2 years ago
Apr 14, 2022
|
Bought 23.6 K USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 19210
|
1.227 USD |
2 years ago
Apr 14, 2022
|
Bought 2.55 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 1916419
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 2.55 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 1916419
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 116 K USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 92370
|
1.26 USD |
2 years ago
Apr 14, 2022
|
Bought 37.8 K USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 30790
|
1.227 USD |
2 years ago
Apr 14, 2022
|
Bought 2.22 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 1665898
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 2.22 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 1665898
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 1.84 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 1381438
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 1.84 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 1381438
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 1.47 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 958209
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.47 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 958209
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.27 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 832949
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.27 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 832949
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.02 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 767952
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 1.02 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 767952
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 1.06 M USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 690719
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.06 M USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 690719
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 587 K USD
|
PURA VIDA INVESTMENTS, LLC
Director |
+ 383976
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 587 K USD
|
PURA VIDA INVESTMENTS, LLC
10 percent owner |
+ 383976
|
1.53 USD |
2 years ago
Apr 14, 2022
|
Bought 1.02 M USD
|
Kamen Efrem
director: |
+ 767952
|
1.3325 USD |
2 years ago
Apr 13, 2022
|
Bought 8 M USD
|
BROADWOOD CAPITAL INC
director: |
+ 6003752
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 8 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 6003752
|
1.3325 USD |
2 years ago
Apr 14, 2022
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
2 years ago
Mar 25, 2022
|
Bought 21 K USD
|
Ross Douglas T.
Chief Scientific Officer |
+ 15000
|
1.4 USD |
2 years ago
Mar 15, 2022
|
Bought 19.8 K USD
|
Paulsen Gisela
Chief Operating Officer |
+ 16500
|
1.198 USD |
2 years ago
Mar 15, 2022
|
Bought 64.1 K USD
|
ANDREWS RONALD ASBURY
Chief Executive Officer |
+ 50000
|
1.283 USD |
2 years ago
Mar 16, 2022
|
Bought 64.1 K USD
|
ANDREWS RONALD ASBURY
Chief Executive Officer |
+ 50000
|
1.283 USD |
2 years ago
Mar 16, 2022
|
Bought 47.6 K USD
|
Redmond Cavan M.
director: |
+ 40000
|
1.189 USD |
2 years ago
Mar 15, 2022
|
Bought 29.1 K USD
|
Levine Mitchell S
Chief Financial Officer |
+ 25000
|
1.166 USD |
3 years ago
Mar 19, 2021
|
Bought 52.7 K USD
|
ANDREWS RONALD ASBURY
Chief Executive Officer |
+ 11000
|
4.7911 USD |
3 years ago
Feb 05, 2021
|
Bought 2.7 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 600000
|
4.5 USD |
3 years ago
Feb 05, 2021
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
3 years ago
Jan 20, 2021
|
Bought 5 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 1460280
|
3.424 USD |
3 years ago
Jan 20, 2021
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
3 years ago
Dec 23, 2020
|
Sell 2.3 K USD
|
KINGSLEY ALFRED D
Director |
- 900
|
2.55 USD |
3 years ago
Dec 21, 2020
|
Sell 75 K USD
|
KINGSLEY ALFRED D
Director |
- 30000
|
2.5 USD |
3 years ago
Dec 22, 2020
|
Sell 19.4 K USD
|
KINGSLEY ALFRED D
Director |
- 7652
|
2.54 USD |
3 years ago
Dec 21, 2020
|
Sell 13.1 K USD
|
KINGSLEY ALFRED D
Director |
- 5148
|
2.54 USD |
5 years ago
Sep 12, 2019
|
Bought 20.1 K USD
|
Levine Mitchell S
CFO |
+ 10000
|
2.006 USD |
4 years ago
Sep 12, 2020
|
Bought 20.1 K USD
|
Levine Mitchell S
CFO |
+ 10000
|
2.006 USD |
4 years ago
Aug 03, 2020
|
Bought 6.65 K USD
|
Parker Albert P
Chief Operating Officer |
+ 5000
|
1.3296 USD |
4 years ago
Aug 03, 2020
|
Bought 6.53 K USD
|
KALAJIAN TONY T
Sr.VP/Chief Accounting Officer |
+ 5000
|
1.3066 USD |
4 years ago
Aug 03, 2020
|
Bought 6.53 K USD
|
KALAJIAN TONY T
Sr.VP/Chief Accounting Officer |
+ 5000
|
1.3066 USD |
4 years ago
Aug 03, 2020
|
Bought 53.9 K USD
|
ANDREWS RONALD ASBURY
Chief Executive Officer |
+ 40000
|
1.347 USD |
4 years ago
Aug 03, 2020
|
Bought 13.2 K USD
|
Levine Mitchell S
Chief Financial Officer |
+ 10000
|
1.32 USD |
4 years ago
Apr 24, 2020
|
Bought 2.38 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 1050000
|
2.27 USD |
4 years ago
Apr 24, 2020
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
4 years ago
Mar 31, 2020
|
Bought 42.7 K USD
|
ANDREWS RONALD ASBURY
CEO and President |
+ 18000
|
2.372 USD |
4 years ago
Mar 31, 2020
|
Bought 42.7 K USD
|
ANDREWS RONALD ASBURY
CEO and President |
+ 18000
|
2.372 USD |
4 years ago
Mar 30, 2020
|
Bought 61.5 K USD
|
ANDREWS RONALD ASBURY
CEO and President |
+ 27216
|
2.258 USD |
4 years ago
Mar 31, 2020
|
Bought 42.7 M USD
|
ANDREWS RONALD ASBURY
CEO and President |
+ 18000
|
2372 USD |
4 years ago
Mar 30, 2020
|
Bought 61.5 K USD
|
ANDREWS RONALD ASBURY
CEO and President |
+ 27216
|
2.258 USD |
4 years ago
Jan 02, 2020
|
Bought 1.34 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 623090
|
2.156 USD |
4 years ago
Jan 02, 2020
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
4 years ago
Jan 02, 2020
|
Bought 1.66 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 768376
|
2.156 USD |
4 years ago
Jan 02, 2020
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
4 years ago
Jan 02, 2020
|
Sell 5.14 M USD
|
Lineage Cell Therapeutics, Inc.
|
- 2383090
|
2.156 USD |
5 years ago
Nov 13, 2019
|
Bought 2 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 1176471
|
1.7 USD |
5 years ago
Nov 13, 2019
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
5 years ago
Sep 17, 2019
|
Bought 108 K USD
|
Arno Andrew
Director |
+ 50000
|
2.1626 USD |
5 years ago
Sep 13, 2019
|
Bought 19.8 K USD
|
KALAJIAN TONY T
SVP-Chief Accounting Officer |
+ 10000
|
1.98 USD |
5 years ago
Sep 13, 2019
|
Bought 19.8 K USD
|
KALAJIAN TONY T
SVP-Chief Accounting Officer |
+ 10000
|
1.98 USD |
5 years ago
Sep 11, 2019
|
Sell 6.64 M USD
|
Lineage Cell Therapeutics, Inc.
10 percent owner |
- 4000000
|
1.66 USD |
5 years ago
Sep 11, 2019
|
Bought 3.32 M USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 2000000
|
1.66 USD |
5 years ago
Sep 11, 2019
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
0 USD |
5 years ago
Sep 12, 2019
|
Bought 20.1 K USD
|
Levine Mitchell S
Chief Financial Officer |
+ 10000
|
2.006 USD |
5 years ago
Jul 05, 2019
|
Sell 4.5 M USD
|
BIOTIME INC
10 percent owner |
- 2250000
|
2 USD |
5 years ago
Jul 02, 2019
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
2 USD |
5 years ago
Feb 08, 2019
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
3.75 USD |
6 years ago
Jul 26, 2018
|
Bought 10 K USD
|
ANNETT WILLIAM
President and CEO |
+ 3500
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 10.5 K USD
|
ANNETT WILLIAM
President and CEO |
+ 3500
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 50 K USD
|
ANDREWS RONALD ASBURY
Director |
+ 17482
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 52.4 K USD
|
ANDREWS RONALD ASBURY
Director |
+ 17482
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 10 K USD
|
Levine Mitchell S
Chief Financial Officer |
+ 3495
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 10.5 K USD
|
Levine Mitchell S
Chief Financial Officer |
+ 3495
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 150 K USD
|
Redmond Cavan M.
Director |
+ 52447
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 157 K USD
|
Redmond Cavan M.
Director |
+ 52447
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 2.5 K USD
|
HESTERBERG LYNDAL K.
Sr VP, Research & Development |
+ 874
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 2.62 K USD
|
HESTERBERG LYNDAL K.
Sr VP, Research & Development |
+ 874
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 20 K USD
|
Last Andrew J.
Director |
+ 6993
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 21 K USD
|
Last Andrew J.
Director |
+ 6993
|
3 USD |
6 years ago
Jul 26, 2018
|
Bought 150 K USD
|
Arno Andrew
Director |
+ 52447
|
2.86 USD |
6 years ago
Jul 26, 2018
|
Bought 157 K USD
|
Arno Andrew
Director |
+ 52447
|
3 USD |
6 years ago
Mar 28, 2018
|
Bought 0 USD
|
BROADWOOD PARTNERS, L.P.
10 percent owner |
+ 0
|
1.26 USD |